OR WAIT null SECS
, LLC (CRI) announced that it has completed the acquisition of
Lifetree Clinical Research®, LC (Lifetree)
The combination enables them to tap into CRI’s experience in Psychiatry and patient population studies as well as Lifetree’s experience in Pain Management and Human Abuse Liability and in performing complex studies.
The acquisition expands CRI’s Clinical Pharmacology capacity to more than 120 beds. The combined organization will provide sponsors with access to more than 6 million people along with a broad range of psychiatry and neurology research products and services at three research sites located in New Jersey, Pennsylvania, and Utah.